Hospital
Grady Memorial Hospital
Grady Memorial Hospital was paid $9.51M by Medicaid between Jan 2018 and Dec 2024, across 193 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoGRADY MEMORIAL HOSPITAL
DELAWARE, OH 43015
DELAWARE, OH 43015
33aNPI1235174327assigned 06/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.51M
24GClaims216,046
24DCodes billed193
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#80 of 101
Median peer was paid$22.32M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BROWNING, MICHAEL controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,095 | $614K | |
| 2019 | 13,820 | $569K | |
| 2020 | 10,179 | $549K | |
| 2021 | 15,362 | $841K | |
| 2022 | 19,383 | $1.12M | |
| 2023 | 83,987 | $3.65M | |
| 2024incomplete | 57,220 | $2.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 18,669 | 16,899 | $2.39M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 12,073 | 10,764 | $1.67M |
| 96361 | Intravenous infusion, hydration; each additional hour | 15% | 4,022 | 2,877 | $1.46M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.3% | 3,560 | 3,031 | $500K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.7% | 3,781 | 3,430 | $351K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.6% | 1,347 | 1,097 | $338K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 2,748 | 2,383 | $306K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 825 | 691 | $196K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.9% | 827 | 622 | $182K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 621 | 500 | $179K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.7% | 648 | 343 | $158K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.6% | 3,075 | 2,436 | $150K |
181 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.6% | 1,801 | $148K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,225 | $146K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 1,537 | $107K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 785 | $96K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 688 | $90K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 306 | $83K |
| 0240U | <1% | 645 | $64K | |
| G0378 | Hospital observation service, per hour | <1% | 1,010 | $60K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 248 | $56K |
| 80053 | Comprehensive metabolic panel | <1% | 5,002 | $55K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,441 | $52K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 149 | $45K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 589 | $38K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 684 | $37K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 782 | $36K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,050 | $35K |
| 93976 | <1% | 211 | $33K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,383 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,268 | $25K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 94 | $25K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 228 | $25K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 310 | $24K |
| 72100 | <1% | 370 | $16K | |
| 82805 | <1% | 605 | $16K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 96 | $16K |
| J3490 | Unclassified drugs | <1% | 1,382 | $15K |
| 71250 | <1% | 157 | $15K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,053 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,675 | $13K |
| 73030 | <1% | 316 | $12K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 747 | $12K |
| 73560 | <1% | 438 | $11K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 38 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,678 | $8K |
| 73630 | <1% | 381 | $8K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 18,613 | $8K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 310 | $8K |
| 74018 | <1% | 242 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,327 | $7K |
| 36591 | <1% | 501 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,557 | $6K |
| 93017 | <1% | 58 | $6K | |
| 93971 | <1% | 59 | $6K | |
| 73130 | <1% | 312 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,729 | $5K |
| 59025 | Fetal non-stress test | <1% | 49 | $5K |
| 84484 | <1% | 2,384 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 29 | $4K |
| 85610 | <1% | 1,661 | $4K | |
| 76642 | <1% | 33 | $4K | |
| 96367 | <1% | 57 | $3K | |
| 73502 | <1% | 130 | $3K | |
| 73610 | <1% | 167 | $3K | |
| 96376 | <1% | 966 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 86 | $3K |
| 72141 | <1% | 12 | $3K | |
| 85027 | <1% | 919 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 27 | $3K |
| J3535 | Drug administered through a metered dose inhaler | <1% | 73 | $2K |
| 81025 | <1% | 1,858 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $2K |
| 73110 | <1% | 72 | $2K | |
| 80320 | <1% | 97 | $2K | |
| 36416 | <1% | 646 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 451 | $2K |
| 80047 | <1% | 850 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 804 | $2K |
| 87081 | <1% | 520 | $2K | |
| 86900 | <1% | 144 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 633 | $1K |
| 80339 | <1% | 97 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,278 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 90 | $1K |
| 82077 | <1% | 877 | $1K | |
| 84703 | <1% | 1,012 | $891.41 | |
| 83605 | <1% | 1,281 | $814.68 | |
| 86850 | <1% | 56 | $802.70 | |
| 72050 | <1% | 15 | $749.02 | |
| 90715 | <1% | 25 | $638.19 | |
| 82248 | <1% | 2,746 | $632.83 | |
| 83735 | <1% | 664 | $598.26 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,793 | $536.84 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,254 | $499.28 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 992 | $490.35 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $460.20 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 17 | $420.56 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 152 | $392.22 |
| 81002 | <1% | 4,055 | $379.75 | |
| 82565 | <1% | 896 | $349.68 | |
| 80051 | <1% | 620 | $330.22 | |
| 83690 | <1% | 2,045 | $320.76 | |
| 81001 | <1% | 1,189 | $268.99 | |
| 83880 | <1% | 574 | $266.13 | |
| 86901 | <1% | 144 | $231.72 | |
| 87077 | <1% | 123 | $229.99 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 520 | $225.93 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,191 | $214.98 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,537 | $201.75 |
| 82375 | <1% | 605 | $200.57 | |
| 82947 | <1% | 935 | $187.11 | |
| 85018 | <1% | 697 | $185.81 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,856 | $180.40 |
| 81003 | <1% | 878 | $161.04 | |
| 99441 | <1% | 16 | $160.56 | |
| 84520 | <1% | 838 | $159.26 | |
| 84702 | <1% | 142 | $158.21 | |
| 85379 | <1% | 477 | $147.54 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,098 | $132.34 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,147 | $120.69 |
| 83050 | <1% | 603 | $116.01 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 153 | $92.32 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 473 | $88.72 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 153 | $81.72 |
| 82150 | <1% | 458 | $73.38 | |
| J1815 | Injection, insulin, per 5 units | <1% | 22 | $67.41 |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 22 | $65.50 |
| 80321 | <1% | 98 | $64.04 | |
| 87186 | <1% | 96 | $55.40 | |
| 82040 | <1% | 457 | $46.63 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,304 | $46.21 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 518 | $44.06 |
| 82247 | <1% | 451 | $43.90 | |
| 84450 | <1% | 457 | $43.90 | |
| 84155 | <1% | 452 | $43.90 | |
| 84460 | <1% | 456 | $43.90 | |
| 84075 | <1% | 451 | $43.90 | |
| 82977 | <1% | 464 | $39.97 | |
| 82330 | <1% | 29 | $33.11 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 785 | $26.86 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,478 | $26.84 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,242 | $21.04 |
| 83992 | <1% | 98 | $20.73 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 209 | $19.58 |
| 80369 | <1% | 98 | $19.26 | |
| 80373 | <1% | 98 | $19.26 | |
| 80356 | <1% | 98 | $19.26 | |
| 80366 | <1% | 98 | $19.26 | |
| 80361 | <1% | 98 | $19.26 | |
| 80360 | <1% | 98 | $19.26 | |
| 80355 | <1% | 98 | $19.26 | |
| 80365 | <1% | 98 | $19.26 | |
| 80325 | <1% | 96 | $19.26 | |
| 80364 | <1% | 97 | $19.26 | |
| 80323 | <1% | 97 | $19.26 | |
| 80348 | <1% | 98 | $19.26 | |
| 80354 | <1% | 98 | $19.26 | |
| 80372 | <1% | 98 | $19.26 | |
| 80346 | <1% | 98 | $19.26 | |
| 80371 | <1% | 97 | $19.26 | |
| 80349 | <1% | 98 | $19.26 | |
| 80352 | <1% | 97 | $19.26 | |
| 80357 | <1% | 97 | $19.26 | |
| 80345 | <1% | 97 | $19.26 | |
| 80358 | <1% | 98 | $19.26 | |
| 80359 | <1% | 98 | $19.26 | |
| 80353 | <1% | 98 | $19.26 | |
| 80368 | <1% | 98 | $19.26 | |
| 84132 | <1% | 47 | $19.26 | |
| 85007 | <1% | 18 | $19.05 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 412 | $15.55 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 67 | $14.37 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 399 | $7.84 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 35 | $6.37 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 415 | $4.56 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,066 | $3.64 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 246 | $3.48 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 19 | $0.85 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 468 | $0.00 |
| 3078F | 0% | 154 | $0.00 | |
| 80076 | 0% | 21 | $0.00 | |
| 1160F | 0% | 526 | $0.00 | |
| 1159F | 0% | 84 | $0.00 | |
| 80179 | 0% | 17 | $0.00 | |
| 3077F | 0% | 37 | $0.00 | |
| 80143 | 0% | 18 | $0.00 | |
| 87040 | 0% | 204 | $0.00 | |
| 3074F | 0% | 223 | $0.00 | |
| 1036F | 0% | 252 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 14 | $0.00 |
| 3079F | 0% | 91 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWNING, MICHAEL (CFO, OHIOHEALTH)
Parent organizationOHIO HEALTH CORPORATION
| Provider | Location | Paid |
|---|---|---|
| Ohiohealth Corporation | Columbus, OH | $214.99M |
| Ohiohealth Corporation | Columbus, OH | $76.95M |
| Ohiohealth Corporation | Columbus, OH | $72.29M |
| Ohiohealth Corporation | Columbus, OH | $44.08M |
| Medcentral Health System | Mansfield, OH | $36.92M |
| Marion General Hospital, INC. | Marion, OH | $36.47M |
| Sheltering Arms Hospital Foundation, INC. | Athens, OH | $26.88M |
| Ohiohealth Berger Hospital LLC | Circleville, OH | $16.38M |
| Ohiohealth Corporation | Dublin, OH | $11.81M |
| Hardin Memorial Hospital | Kenton, OH | $7.27M |
| Medcentral Health System | Mansfield, OH | $3.13M |
| Madison Family Health Corporation | London, OH | $1.03M |
| Marion General Hospital, INC. | Marion, OH | $683K |
| Medcentral Health System | Mansfield, OH | $477K |
| Sheltering Arms Hospital Foundation | Athens, OH | $435K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.